Research News
View articles by month and year
-
DCIS Recurrence Risk Overestimated by Many Women
Many women overestimate the risk of DCIS coming back.
-
Genetic Test Can Predict Recurrence Risk, Help Make Treatment Decisions
The Oncotype DX test can help determine who will benefit from hormonal therapy plus chemotherapy, as opposed to hormonal therapy alone, in post-menopausal women diagnosed with estrogen-receptor-positive, node-positive breast cancer.
-
Gaining Weight After Diagnosis Decreases Survival
Women who gain weight after being diagnosed with breast cancer have a worse prognosis than women who don't gain weight.
-
Non-White Women Have More Breast Cancer Pain
Non-white women have more severe pain with advanced breast cancer than white women.
-
Recurrence After Lumpectomy Higher in African American Woman Than Whites
A new study adds to research saying that lumpectomy plus radiation therapy is a good option for African American women with early breast cancer.
-
More Breast Cancer Diagnosed in China
Breast cancer incidence has increased sharply in China, mainly due to lifestyle factors.
-
More Asian Women Being Diagnosed with Breast Cancer
Breast cancer rates are increasing among women, especially younger women, living in Asian countries.
-
Breast Cancer Diagnoses and Deaths Down
Breast cancer diagnosis and death rates continue to decline overall, but African American women are not experiencing these same declines.
-
Measuring Circulating Tumor Cells May Help Determine Recurrence Risk
A test that measures circulating tumor cells in the blood may help doctors more accurately determine the risk of breast cancer recurrence.
-
Women with Abnormal BRCA1 Gene Have Worse Prognosis Than Women with Abnormal BRCA2 Gene
A new study suggests that having an abnormal BRCA2 gene has a better prognosis 5 years after diagnosis than having an abnormal BRCA1 gene.
